Lung Cancer

Lung Cancer

Lung Cancer. Now What? Plans and How We “Navigate” Them

Amy M. Norton, RN, MSN, ONN-CG(T)1; Dawn M. Deacon, RN, BSN, OCN, ONN-CG1; Wendy L. Brooks, RN, ONN-CG(T)1; Erin L. Terwilliger, RN, BSN, ONN-CG2
1Sarah Cannon Cancer Institute – HCA Midwest Division; 2AstraZeneca Pharmaceuticals LP 

Ali Mokdad, PhD, reported in JAMA that “cancer mortality rates in the United States dropped from 240.2 to 192.0 per 100,000 population between 1980 and 2014.”1 However, according to the [ Read More ]

Lung Cancer

Practice-Changing Results: PD-L1 Inhibitor Consolidation Therapy for NSCLC

Durvalumab, a PD-L1 inhibitor, improved progression-free survival (PFS) by 11.2 months compared with placebo in patients with locally advanced, unresectable stage III non–small cell lung cancer (NSCLC) that did not [ Read More ]

Lung Cancer

Regular CT Scans During Follow-Up May Not Be Necessary

Findings of a randomized study suggest that follow-up CT scans may not be needed every 3 to 6 months during the first 2 years after surgery for patients with non–small [ Read More ]

AONN+ West Coast Regional Meeting, Lung Cancer

There’s Power in Numbers: Establishing a Group Smoking Cessation Program

The Surgeon General’s warning against cigarette smoking was put on packs in 1965, and 50 years later, approximately 18% of Americans still smoke. Cigarettes cause almost all tobacco-related diseases and [ Read More ]

Lung Cancer

Longest Follow-Up in NSCLC Responders to Immunotherapy

In the longest follow-up on single-agent nivolumab to date, 5-year overall survival (OS) was 16% in patients with advanced non–small cell lung cancer (NSCLC) in updated results from a phase [ Read More ]

Lung Cancer

Multidisciplinary Care Preferred by Caregivers, Patients with Lung Cancer

Christine Erickson 

The multidisciplinary care model is perceived to be more patient-centered and efficient for patients with lung cancer than the serial care model, according to Satish K. Kedia, PhD, Professor, Division [ Read More ]

Lung Cancer

Lung Cancers and Stigma: Perception or Reality?

Caroline Kornhauser, MPH 

Who can I blame? I am 67 years old and have been a heavy smoker all my life. I have lived with chronic obstructive pulmonary disease, and was just diagnosed [ Read More ]

Lung Cancer

Effective Lung Cancer Screening

Meg Barbor 

“There’s a lot we don’t know about lung cancer screening,” according to Denise Aberle, MD, who spoke at the recent American Association for Cancer Research International Conference on Frontiers in [ Read More ]

AONN+ Conference Highlights, Lung Cancer, Nurse Navigation

Thoracic Cancer Navigation

Lisa A. Raedler, PhD, RPh 

Memphis, TN—On Sunday, November 17, 2013, a series of breakout sessions were conducted to highlight navigation challenges in the context of specific tumor types. Experts in the development of navigation [ Read More ]

Lung Cancer

Assuring Lung Nodule Surveillance: A Navigation Model

Gean Brown, RN, OCN 

The American Cancer Society reports that lung cancer is the leading cause of cancer death for both men and women and that more people die each year from lung cancer [ Read More ]

AONN+ Conference Highlights, Lung Cancer

Lung Cancer Navigation

Pamela Matten, RN, BSN, OCN 

As one of the most lethal cancers in the world, lung cancer presents numerous challenges in diagnosis and management. New evidence from the National Lung Screening Trial indicates that screening [ Read More ]

Lung Cancer

Maintenance Therapy For Non–Small Cell Lung Cancer

Improving outcomes for patients with non– small cell lung cancer (NSCLC) is particularly relevant because NSCLC accounts for 85% of all cases of lung cancer.1 In the appropriate patients with [ Read More ]

Lung Cancer

Maintenance Therapy For Non–Small Cell Lung Cancer

Contributions By Loretta Fala 

Lung cancer is the most common type of cancer in the United States.1,2 An estimated 221,520 people (115,750 men and 105,770 women) will be diagnosed with cancer of the lung [ Read More ]